UBS Group’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

UBS Group’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-288,616	Closed	-$11.9M	–	8996
2015 Q2	$11.9M	Buy	288,616 +250,679	+661%	+$8.99M	0.01%	1334
2015 Q1	$1.34M	Buy	37,937 +14,170	+60%	+$479K	﹤0.01%	3309
2014 Q4	$764K	Buy	+23,767	New	+$687K	﹤0.01%	3796

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

UBS Group's BRLI Position: Q3 2015 in Review

UBS Group sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 288,616 shares — an estimated $11.9M sold.

UBS Group first reported a position in BRLI in Q4 2014 and held it in 3 quarters. The position peaked at $11.9M in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

UBS Group reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
UBS Group sold 288,616 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $11.9M.
UBS Group first reported a position in BIO-REFERENCE LABS INC-NEW- in Q4 2014 and held it in 3 quarters.
UBS Group's BIO-REFERENCE LABS INC-NEW- position peaked at $11.9M in Q2 2015.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on UBS Group's 13F filing for Q3 2015, filed 13 Nov 2015.